Solution
Industries
Resources
About
  1. Press Releases
  2. 2009
  3. Pharmaceuticals

The Global Influenza Market

September 16, 2009

 

Wellesley, Mass. – According to a new technical market research report, THE GLOBAL INFLUENZA MARKET (PHM049B) from BCC Research (www.bccresearch.com), the global market for products used in the fight against influenza will be worth an estimated $5.5 billion in 2009. That is expected to increase to $6.3 billion in 2014, for a compound annual growth rate (CAGR) of 2.7%.

The market is broken down into vaccines, therapeutics and diagnostic products. The vaccines segment has the largest share of the market, worth an estimated $3.2 billion in 2009. This segment is expected to grow at a CAGR of 5.6% to reach nearly $4.2 billion in 2014.
 
The therapeutics segment has the second-largest share of the market with $2.1 billion in 2009. But that segment is expected to decrease at a CAGR of –2.4%, falling to $1.9 billion in 2014.
 
SUMMARY FIGURE
GLOBAL INFLUENZA MARKET ANALYSIS BY PRODUCT SEGMENT, 2007-2014
($ MILLIONS)
GLOBAL INFLUENZA MARKET ANALYSIS BY PRODUCT SEGMENT, 2007-2014
To Contact us, click here  help


Source: BCC Research
 
An aging population is a significant driver in the growth of the market, boosting sales for products directed to preventive measures while the international market continues to show promise in vaccination, treatment, and diagnosis.
 
The influenza market consists of products to prevent, treat and diagnose influenza viruses during both seasonal and pandemic episodes. Also included in the market is the stockpiling efforts and spending on new vaccine/therapeutic contracts.
 
As many as 500,000 people die of influenza annually and, with the threat of a pandemic, government agencies and disease-prevention organizations are devoted to gaining control of the situation. Many companies have been asked to assist with the problem and others are furthering their position with backing from government agencies. The next 5 years will continue to display support and funding for many research and development programs, product development and pandemic prevention and/or control by worldwide governments, organizations, and health professionals. 

The study includes information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers. A special emphasis on U.S. and European markets is discussed.

The Global Influenza Market( PHM049B )
Publish Date: Sep 2009    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.

BCC Library Membership Benefits

Unlimited Access to Market Research Reports for Academic Institutions and Corporations.

Custom Research

Tailored solutions across industries for your unique business needs.

The Global Influenza Market
Customize This Report

More in Pharmaceuticals

Reports from Pharmaceuticals

Recent News

Browse by Year

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment